Authors: Nimmanapalli, R Porosnicu, M Nguyen, D Worthington, E O'Bryan, E Perkins, C Bhalla, K

Citation: R. Nimmanapalli et al., Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells, CLIN CANC R, 7(2), 2001, pp. 350-357

Authors: Porosnicu, M Nimmanapalli, R Nguyen, D Worthington, E Perkins, C Bhalla, KN

Citation: M. Porosnicu et al., Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells, LEUKEMIA, 15(5), 2001, pp. 772-778

Authors: Nimmanapalli, R O'Bryan, E Bhalla, K

Citation: R. Nimmanapalli et al., Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts, CANCER RES, 61(5), 2001, pp. 1799-1804

Authors: Nimmanapalli, R Perkins, CL Orlando, M O'Bryan, E Nguyen, D Bhalla, KN

Citation: R. Nimmanapalli et al., Pretreatment with paclitaxel enhances Apo-2 ligand tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cellsby inducing death receptors 4 and 5 protein levels, CANCER RES, 61(2), 2001, pp. 759-763